Analysis Renalytix AI PLC (RENX)
6/3/2024
Analysis of Renalytix AI PLC (RENX)
Renalytix AI PLC (RENX) has been showing a downward trend in the recent days. The stock price closed at 14.00 on the most recent trading day, with a low of 13.00 and a high of 14.75. The Relative Strength Index (RSI) is at 19.32, indicating that the stock may be oversold.Looking at the Moving Average Convergence Divergence (MACD) indicator, the MACD line is below the signal line, with a negative value of -3.04. This suggests a bearish momentum in the stock.
In terms of moving averages, the Simple Moving Average (SMA) is at 22.07, the Exponential Moving Average (EMA) is at 22.21, and the Weighted Moving Average (WMA) is at 20.92. All these moving averages are above the current stock price, indicating a potential resistance level.
Overall, based on the RSI, MACD, and moving averages, Renalytix AI PLC may continue to face downward pressure in the near term. Investors should closely monitor the stock for any potential reversal signals before making any trading decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 9.7%
- The past 5 years compound annual growth rate (CAGR) is 20.1%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth rate projected for the next year. The consistent growth rates for the next quarter and current quarter suggest stability in the short term. The next 5 years also show a positive outlook for the company's growth trajectory.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions. Investors should consider these factors when making decisions about buying or selling the security.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility with a beta of 1.264 and a change in the fifty-two week range.
Valuation metrics indicate a high PEG ratio and price to book ratio, with the company's market capitalization and enterprise value also provided.
Lastly, dividends and splits information show the company's dividend dates, payout ratio, and dividend yields, along with details on past splits.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four fiscal years.
2. The EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) have also shown a positive trend, indicating improving operational efficiency.
3. The net income has been growing consistently, reflecting the company's profitability.
4. The basic and diluted earnings per share (EPS) have remained relatively stable over the years.
5. The company has been able to manage its operating expenses effectively, as seen in the operating income figures.
6. Despite fluctuations in non-operating interests and other income/expenses, the company has maintained a strong financial performance.
7. The number of basic and diluted shares outstanding has remained relatively constant, indicating no significant dilution of shares.
8. Overall, the financial performance of the company, as indicated by its revenues, has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, with a significant portion allocated to machinery, furniture, and equipment.
4. Total liabilities have also been on the rise, with the highest value recorded at $302,083,000,000 in 2022.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities primarily comprise long-term debt and other non-current liabilities.
7. Shareholders' equity has shown variations, with the highest value of $107,147,000,000 in 2018.
8. Common stock and retained earnings are the main components of shareholders' equity.
9. The company seems to be investing heavily in non-current assets, which could indicate growth strategies.
10. The fluctuation in cash and cash equivalents might suggest varying liquidity positions over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. Looking ahead to the next quarter ending on September 30, 2024, analysts project an average EPS of $1.42, ranging from a low estimate of $1.33 to a high estimate of $1.51. This is higher than the EPS of $1.35 reported in the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous fiscal year.
4. Looking further ahead to the next fiscal year ending on September 30, 2025, analysts anticipate an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This shows a slight increase from the EPS of $6.10 in the current fiscal year.
Overall, the estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
MACD of RENX
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
